The ratio of phosphorylated and hence nuclear translocated STAT5 to RELA expression (NF-κB transcriptional effector) correlates with B-ALL patient survival and disease remission [185]. The gene discussed is STAT5A; the disease is acute lymphoblastic leukemia.